<SEC-DOCUMENT>0001213900-19-013427.txt : 20190724
<SEC-HEADER>0001213900-19-013427.hdr.sgml : 20190724
<ACCEPTANCE-DATETIME>20190724083026
ACCESSION NUMBER:		0001213900-19-013427
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190723
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190724
DATE AS OF CHANGE:		20190724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		19969289

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k072319_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): July 23, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>OptimizeRx
Corporation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-53605</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26-1265381</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <BR>
of incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    File Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <BR>
Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248.651.6568</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Former name or former address, if changed since last report)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 96%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&nbsp;&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="width: 2%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    symbol</B></FONT></TD>
    <TD STYLE="width: 2%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPRX</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8 &ndash; Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                          8.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2019, we issued a press release announcing a new partnership and integration with NextGen Healthcare, Inc. (Nasdaq: NXGN).
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9 &ndash; Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                          9.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="f8k072319ex99-1_optimize.htm">Press release, dated July 23, 2019</A></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
    Corporation</B></FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Douglas Baker</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Baker</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    July 24, 2019</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k072319ex99-1_optimize.htm
<DESCRIPTION>PRESS RELEASE, DATED JULY 23, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Establishes Direct Partnership and Integration with NextGen Healthcare</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>More
Than 55,000 Prescribers on the NextGen&reg; Enterprise Network Will Have Immediate Access to OptimizeRx&rsquo;s Point-of-Care
Platform That Links the Pharma-Physician-Patient-Payor Continuum </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ROCHESTER,
Mich. &ndash; July 23, 2019 &ndash; </B>OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the
pharmaceutical industry, announced a new partnership and integration with NextGen Healthcare, Inc. (Nasdaq: NXGN). Providers using
NextGen&reg; Enterprise&mdash;a full suite of comprehensive technology solutions including electronic health record (EHR), practice
management (PM) and revenue cycle management (RCM) solutions&mdash;will have immediate access to OptimizeRx&rsquo;s real-time
cloud-based platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Teaming
up with OptimizeRx allows us to provide our clinicians real-time access to valuable pharmaceutical data and insights that promote
affordability and enhance quality care. As a result, patients can better access and afford medications vital to their overall
well-being,&rdquo; said John S. Beck, Chief Solutions Officer and Executive Vice President, NextGen Healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OptimizeRx platform will integrate directly into NextGen Enterprise&rsquo;s EHR workflow, enabling the extensive 55,000+ prescriber
network real-time access to critical information from key pharma manufacturers. Providers have access to patient savings opportunities
for many prescribed medications&mdash;a particularly pertinent need of patients as a recent report by TransUnion Healthcare indicated
a 12 percent increase in out-of-pocket healthcare costs in 2018. Additionally, direct EHR integration means providers can, at
the point of care, deliver patient support and brand enrollment beyond the e-coupon to support adherence and care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Given
the financial landscape in today&rsquo;s healthcare environment, it&rsquo;s more critical than ever that we work together to bridge
the communications gap between key stakeholders in the care journey: providers, patients and the pharma industry,&rdquo; said
Will Febbo, CEO at OptimizeRx. &ldquo;Our partnership with NextGen Healthcare, the leading provider of ambulatory-focused technology
solutions, will allow us to empower providers with critical patient savings opportunities from the pharma industry&mdash;thus
empowering the patient with lowered costs and improved adherence rates. This marks a significant step in the direction towards
improving quality care.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on OptimizeRx, its platform or its partners, visit www.optimizerx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
OptimizeRx</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OptimizeRx&reg;
(Nasdaq: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability,
adherence and brand awareness at the point-of-care. As the nation&rsquo;s largest point-of-prescribe promotional platform for
the pharmaceutical industry,&nbsp;OptimizeRx&nbsp;provides a direct channel for&nbsp;pharma&nbsp;companies to communicate with
healthcare providers right within their workflow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cloud-based solution supports patient adherence to medications with real-time access to financial assistance, prior authorization,
education and critical clinical information.&nbsp;OptimizeRx&nbsp;provides more than half of the ambulatory patient market with
access to these benefits through leading EHR platforms like&nbsp;Allscripts, Amazing Charts and Quest, and directly via its mobile
communications platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
more information, follow the company on&#8239;Twitter,&#8239;LinkedIn&#8239;or visit&#8239;www.optimizerx.com.&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
NextGen Healthcare, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NextGen
Healthcare provides a range of software, services, and analytics solutions to medical and dental group practices. The company's
portfolio delivers foundational capabilities to empower physician success, enrich the patient care experience, and enable the
transition to value-based healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Visit
www.nextgen.com for additional information. Follow NextGen Healthcare on Facebook, Twitter, LinkedIn and Instagram.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended,
and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make
an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements,
which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently
subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties
to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition
and other material risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx&nbsp;Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Doug
Baker, CFO&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(248) 651-6568 x807&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dbaker@optimizerx.com&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Relations Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicole
Brooks,&nbsp;Innsena&nbsp;Communications&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel&nbsp;(860)&nbsp;800-2344&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nicolebrooks@innsena.com&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both, CMA&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 432-7557&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">oprx@cma.team&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NextGen
Healthcare Media Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Priya
Dua</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 237-5254</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pdua@nextgen.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ 3T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^]S7_ !'H
M7A?0]7\2^(M9TS0?#OA_3;[6==UW5[RWT[2='TC3;1]0U#4]3U"[>*UL;"RL
M8I;R[NKB6.&"VC>:1UC5F'\D_P"T3_P76_:N_:\^,^K?LL?\$9_@W=^/KZS,
ML6I_M!:WX?AU.66P:X-K<>*_#.C>)WMO!'@'P0+M#;Z9XU^*DET_B&66WBT7
MPQ9330--T/\ P<@?M6_$SQ/KOP"_X)=?L_7%U-X]_:4U'PWJ_P 3K;39I$FU
MK0=?\61>%OAE\.]3N+287MKH>O\ B>SU;Q3XWB>&,RZ%X:T]W8:?J.H1']W?
M^">G[ OPF_X)[_L\>%O@O\-=.L;KQ!-:6.K?%OXBFSA@\1?$[X@R6H35O$6I
MWD:13QZ/9RR7%AX0\/;OLWAK0%M[.!I[PW][?^E1I4L)A88K%TX5,15JU?JT
M))^S5"'*XSDOB<IW5[246TK*USIBHTH1G)*3G?E3UMR^7G?_ (8_GWTK_@B_
M_P %J/CG:_\ "4?M(?\ !5CQ3X$\0:A,UXWA/P=XX^+'BFTTIY_O6Y_X177/
MA5X5TX0]M.\-Z:VGG/RWY'-4=:_X)6?\%YOV5X/^$U_9=_X*/:K\=;C1%-ZW
MP]\:>-?%-K_; M1FWL%\._&-_B!X!UPS#(9]:UO1HUP=S8-?V$A2. WZ"DVG
MD8 !&T$'Y@.>3G@X//!)SDY-3_:M?FC-TL-*"_Y=2I/D47IHHS3TWWO^)/MG
M?X*=O\+_ ,[G\M7[!W_!?/QA!\9;?]CG_@J=\+S^S5\?(-2LO"VF_$R\TB]\
M'>#-6\17LXM=*T_XB>&]2GFM/ USXBN#G0_&>A:GJGP^UYIHF2;0;>2'=_4L
M)$;&TY!. 0&(SW&<8XQ@\\'Y3SQ7XM_\%GO^"9/@W]O_ /9G\3:KH/A[3(?V
MF_A'X;UGQ!\%_%T4"6VK:U%9PMJ>L_"/7[_RS<:GX5\<Z>MQ906NHO,FA^*;
MJS\06/V0+J,-[X)_P;G_ +>/B7]JW]DC5_@U\5-8N]8^,/[*FI:+X$NM2UBY
MDFU_Q!\,M2TZ27X>ZMK,USBXOM6T<:9JW@W6=0E9KJZFT"RO=26*ZOR7>)HP
MQ&&EC,)%1J0<?K-'_EU!3?NRII>\DTI74I2^SKN5.*J1YX12Y?CMMKM^3^7G
M<_H@W*>_Z'_"ER/?\C_A4>^-3C// X5FSE]AP0#G:W$F/]7P9-H()BDFMX(I
M+B>9;>WACFEGGG80Q0Q6^3-++,^V..-%4N7=@IC5I 2@+#RVW[K323VO%R<G
MU2MM;YWOH<WR98W#KGCUP?\ "G5PVG_$SX<ZKJ TC2?'W@S5-58[5TRP\4Z)
M>Z@Q]!9V]])<G\(B/SKM#-$I4&09<D(#U8A2Y5 !\S[ SA!EBJLP!"L13YDE
MS0J+SE3E%/\ P\R5_.U^@FIIZI)/:Z=_,D) ZTTR(,<]21P"1D'!!(!P<@KS
MC+#:.>*1WC ^9@.0 3Q\Q8(HR<#+L=J G+G.W."1_)9_P5]\8>+='_X+D_\
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M+W4[!KJ^=[NX,4C+<M]Q=S+&1DA._P"\9 //(([CK7\LO_!4G_D\;QA[^#O
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MWPMH-GJ/V'3?%6I:!(+F\\/:S=B'^T[=8-.EDN88=)O]/^WQ:=J?G$L\:O\
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MC"$;N,4F[7:6KMM=_,.EOZ7H-8,<8SWSSCTI1G'/6EHIM)_YK< HHHHMK?\
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E5'Y#'\S2,A)R,?Y_/^E/HJ)4J<OBBGYZW?SO<-?YF_6W^1__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
